Skip to main content
. Author manuscript; available in PMC: 2016 Aug 11.
Published in final edited form as: Bioorg Med Chem. 2009 Jul 3;17(16):5974–5982. doi: 10.1016/j.bmc.2009.06.063

Figure 1.

Figure 1

Various 3-cyano-2-oxopyridine derivatives with potential growth inhibitory and/or antiangiogenic actions through PIM-1 kinase inhibition (compound 1), survivin inhibition (compound 2) or PDE3 inhibition (compound 3).